Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Myeloid, Chronic-Phase 6Leukemia 5Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Blast Crisis 1

Interventions

Cyclophosphamide 37fludarabine phosphate 33Peripheral Blood Stem Cell Transplantation 29Methotrexate 27Busulfan 26Tacrolimus 24Cytarabine 21Antilymphocyte Serum 20Cyclosporine 19Mycophenolic Acid 18Whole-Body Irradiation 17Radiotherapy 15Methylprednisolone 15Filgrastim 13merphos 10Melphalan 10Cord Blood Stem Cell Transplantation 10Imatinib Mesylate 9Etoposide 9Granulocyte Colony-Stimulating Factor 7Thiotepa 6Rituximab 6sargramostim 5fludarabine 5Vincristine 5Sirolimus 5Prednisone 5Idarubicin 5Cladribine 5thymoglobulin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Blast Crisis × Homoharringtonine × Clear all
NCT00114959 2015-01-15

Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
15 enrolled 6 charts
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡